IRF4 and neoplasm: Our finding is consistent with a previous study which shows that IRF4 functions as tumor suppressor in BCR/ABL oncogene induced B-ALL and further demonstrates that IRF4 is capable of functioning as a tumor suppressor against a broad spectrum of oncogene insults at the pre-B stage.